The 20 Best Renal Cell Carcinoma (RCC) Doctors Near Me in Hackensack, NJ

Michael Stifelman is a Urologist practicing medicine in Hackensack, New Jersey. Dr. Stifelman is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), UPJ Obstruction, Retroperitoneal Fibrosis, Nephrectomy, and Ureteral Reconstruction. Dr. Stifelman is board certified in American Board Of Urology.

Robert Alter is an Otolaryngologist practicing medicine in Hackensack, New Jersey. Dr. Alter is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 42 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Familial Prostate Cancer, Urothelial Cancer, Endoscopy, and Nephrectomy.

James McKiernan, MD, is the John K. Lattimer Professor of Urology and CEO of ColumbiaDoctors. He is also Senior Vice Dean for Clinical Affairs for Columbia University Vagelos College of Physicians and Surgeons. Dr. McKiernan graduated from Johns Hopkins University with a BA in biology and received his MD from Columbia University College of Physicians and Surgeons. He completed his training in urology and general surgery at NewYork-Presbyterian Hospital, followed by a urologic surgical oncology fellowship at Memorial Sloan-Kettering Cancer Center. Dr. McKiernan's clinical practice is focused on urologic oncology and particularly on surgical therapy in high-risk patients with bladder and kidney cancers. Dr. McKiernan evaluates and treats over 1,000 patients with bladder cancer every year. His research, funded by NIH and biotechnology industry grants, focuses on developing novel therapeutics for bladder cancer treatment as well as comparative effectiveness research in urologic oncology. In the management of kidney and bladder cancer, he has special expertise in organ preservation and reconstructive surgery to maximize quality of life. Dr. McKiernan's research has been published in Cancer, Cancer Research, the Journal of Clinical Oncology, JAMA Oncology, Journal of Urology, Urologic Oncology, and Urology. He has authored and co-authored more than 220 scientific articles and book chapters on urologic cancer and related issues.For the past 10 years, he has directed a research team at Columbia University Medical Center investigating quality outcomes and effectiveness in urologic cancer surgery. He has served as the Vice Chairman for the AJCC TNM Staging Task Force, Co-Chair of the AUA Guidelines Panel on non-muscle invasive bladder cancer, as well as on the American Board of Urology and Society of Urologic Oncology Examination Committees. In addition, Dr. McKiernan is the principal investigator of the NIH-funded clinical trials program of experimental therapeutics in bladder cancer at Columbia University/NYPH, which is investigating new agents for bladder preservation in patients whose cancer has recurred after standard therapy. In collaboration with researchers at Columbia's Herbert Irving Comprehensive Cancer Center, his team continues to develop new therapeutic strategies for managing bladder cancer. Dr. Mckiernan is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Urothelial Cancer, Cystectomy, and Nephrectomy. Dr. Mckiernan is board certified in Urology. Dr. Mckiernan is currently accepting new patients.

Ravi Munver is a Urologist practicing medicine in Hackensack, New Jersey. Dr. Munver is rated as a Distinguished provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 34 other conditions, according to our data. His clinical expertise encompasses Horseshoe Kidney, Prostate Cancer, Muscle Invasive Bladder Cancer, Nephrectomy, and Reconstructive Urology Surgery. Dr. Munver is board certified in American Board Of Urology.

Mutahar Ahmed is a Urologist practicing medicine in Maywood, New Jersey. Dr. Ahmed is rated as a Distinguished provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 44 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Bladder Cancer, Ureterocele, Nephrectomy, and Ureteral Reconstruction. Dr. Ahmed is board certified in American Board Of Urology.

Gregory Lovallo is an Oncologist practicing medicine in Maywood, New Jersey. Dr. Lovallo is rated as a Distinguished provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 51 other conditions, according to our data. His clinical expertise encompasses Obstructive Uropathy, Muscle Invasive Bladder Cancer, Enlarged Prostate (BPH), Nephrectomy, and Reconstructive Urology Surgery. Dr. Lovallo is board certified in American Board Of Urology.

Ketan Badani is a Urologist practicing medicine in New York, New York. Dr. Badani is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Prostate Cancer, Nephrectomy, and Prostatectomy.

Reza Mehrazin is a Urologist practicing medicine in New York, New York. Dr. Mehrazin is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 41 other conditions, according to our data. His clinical expertise encompasses Urothelial Cancer, Bladder Cancer, Renal Cell Carcinoma (RCC), Nephrectomy, and Cystectomy. Dr. Mehrazin is currently accepting new patients.

Robert Motzer is an Oncologist practicing medicine in New York, New York. Dr. Motzer is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Teratoma of the Mediastinum, Nephrectomy, and Orchiectomy. Dr. Motzer is currently accepting new patients.

Paul Russo is a Urologist practicing medicine in New York, New York. Dr. Russo is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Wilms Tumor, Nephrectomy, and Reconstructive Urology Surgery. Dr. Russo is currently accepting new patients.

Martin Voss is an Oncologist practicing medicine in New York, New York. Dr. Voss is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Clear Cell Sarcoma, and Nephrectomy. Dr. Voss is currently accepting new patients.

Jonathan Coleman is a Urologist practicing medicine in New York, New York. Dr. Coleman is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Upper Tract Urothelial Carcinoma (UTUC), Renal Cell Carcinoma (RCC), Urothelial Cancer, Nephrectomy, and Prostatectomy. Dr. Coleman is currently accepting new patients.

Ritesh Kotecha is an Oncologist practicing medicine in New York, New York. Dr. Kotecha is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Prostate Cancer, and Nephrectomy. Dr. Kotecha is currently accepting new patients.

Darren Feldman is an Oncologist practicing medicine in New York, New York. Dr. Feldman is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Testicular Cancer, Teratoma of the Mediastinum, Renal Cell Carcinoma (RCC), Orchiectomy, and Nephrectomy. Dr. Feldman is currently accepting new patients.

Abraham Hakimi is a Urologist practicing medicine in New York, New York. Dr. Hakimi is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Nephrectomy, and Reconstructive Urology Surgery. Dr. Hakimi is currently accepting new patients.

Maria Carlo is an Oncologist practicing medicine in New York, New York. She has been practicing medicine for over 17 years. Dr. Carlo is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Lynch Syndrome, Nephrectomy, and Splenectomy. Dr. Carlo is currently accepting new patients.

Neil Shah is an Oncologist practicing medicine in New York, New York. Dr. Shah is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), WT1-Related Wilms Tumor Syndromes, Chromophobe Renal Cell Carcinoma, and Wilms Tumor. Dr. Shah is currently accepting new patients.

Cora Sternberg is an Oncologist practicing medicine in New York, New York. Dr. Sternberg is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Prostate Cancer, Urothelial Cancer, Renal Cell Carcinoma (RCC), Orchiectomy, and Nephrectomy. Dr. Sternberg is currently accepting new patients.

Douglas Scherr is a Urologist practicing medicine in New York, New York. Dr. Scherr is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 31 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Urothelial Cancer, Upper Tract Urothelial Carcinoma (UTUC), Cystectomy, and Nephrectomy. Dr. Scherr is currently accepting new patients.

Lee Richstone, MD is the Chairman of Urology and Director of Urology Services for the Western Region. He is also Director of Laparoscopic and Robotic Surgery at Lenox Hill Hospital and System Vice Chairman for Education for Northwell Health Urology. Dr. Richstone is Professor of Urology at The Hofstra-Northwell School of Medicine. Dr. Richstone completed medical school at the Cornell University Medical College in New York City. There he won early acceptance into Alpha Omega Alpha (AOA), the prestigious national medical honor society. He pursued his urologic training and chief residency at New York Presbyterian (Weill-Cornell) and Memorial Sloan Kettering hospitals. Dr. Richstone completed his fellowship training in urologic laparoscopic and robotic surgery and joined the North Shore Long Island Jewish Health System in 2007 as Director of Laparoscopic and Robotic Surgery. He then served as Chief of Urology for the North Shore University Hospital, then Chief of Urology at the Long Island Jewish Medical Center, before assuming the role of Chairman of Urology at Lenox Hill Hospital in Manhattan. Dr. Richstone is an internationally recognized urologic surgeon who has helped pioneer laparoscopic and robotic surgery for cancer of the prostate, kidney and bladder, as well as for various forms of urinary obstructions. He has over 90 peer-reviewed publications in leading national and international journals including The Journal of Urology, Urology, The British Journal of Urology, The Journal of Endourology, Cancer, and Cell.Dr. Richstone is a robotic surgery specialist having performed well over 1000 operations. This includes surgeries for prostate, kidney and bladder cancer and complex neobladder reconstructions completely robotically. His focus is on preserving urinary continence and sexual function. Dr. Richstone has also pioneered Laparoendoscopic Single Site Surgery (LESS), where entire laparoscopic operations are performed only through the belly button. Dr. Richstone is one of only a few surgeons in the United States to have performed single site partial nephrectomy and prostatectomy.Dr. Richstone is a member of the Society of Urologic Oncology (SUO), the America Urological Association (AUA), and the Endourological Society (EUS). Dr. Richstone is the recipient of numerous honors and awards, including acceptance into Alpha Omega Alpha (AOA), the E. Darracott Vaughan Prize for Excellence in Urology (2000), The Ferdinand C. Valentine Urology Essay Prize (First Place, 2005), The American Urological Association-Ambrose Reed Socioeconomic Essay Contest (First Place, 2005), and the Weill-Cornell Distinguished House Officer Award (2005). Dr. Richstone was awarded the Stryker and Nagamatsu Fellowship (2007), and won first prize at the Endourology Society Fellowship Paper Award the same year. Dr. Richstone won first prize at the AUA Research Foundation for Outstanding Research awarded at the 2010 AUA National Meeting in San Francisco. Dr. Richstone is rated as a Distinguished provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Renal Cell Carcinoma (RCC), Muscle Invasive Bladder Cancer, Cystectomy, and Nephrectomy. Dr. Richstone is board certified in American Board Of Urology.